4
Changes in Ownership
Syndax Pharmaceuticals Inc Filed Acc 0001562180-22-001072
Director acquired 16,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Egros Fabrice Director | 2022-02-02 | Grant or award | +16,000 | 32,000 | D: show line 1 in the form |
Loading xslF345X03/primarydocument.xml…